Adial Pharmaceuticals
ADIL
14 hedge funds and large institutions have $236K invested in Adial Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
0% more funds holding
Funds holding: 14 → 14 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
7.24% less ownership
Funds ownership: 21.84% → 14.61% (-7.2%)
60% less capital inflows, than outflows
Capital inflows: $133K | Capital outflows: $329K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HRT Financial
New York
|
+$53.6K |
| 2 |
Renaissance Technologies
New York
|
+$41.8K |
| 3 |
Virtu Financial
New York
|
+$30.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.14K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$2.81K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Armistice Capital
New York
|
-$296K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$27.5K |
| 3 |
JP Morgan Chase
New York
|
-$4.65K |
| 4 |
Focused Wealth Management
Newburgh,
New York
|
-$1.02K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$37 |
ADIL Hedge Fund Activity: Q1 2024 in Review
14 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals (ADIL) for Q1 2024, worth a combined $236K — down 52% from $495K a quarter earlier.
Fund positioning in ADIL was balanced in Q1 2024: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 1 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $53.6K. The largest seller was Armistice Capital, exiting entirely with an estimated $296K sold.
- 14 institutional investors held Adial Pharmaceuticals (ADIL) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $236K of Adial Pharmaceuticals stock for Q1 2024, down 52% quarter-over-quarter.
- 4 funds opened new Adial Pharmaceuticals positions in Q1 2024 and 4 closed out, a net change of 0 holders.
- The largest Adial Pharmaceuticals buyer in Q1 2024 was HRT Financial, an estimated $53.6K added.
- The largest Adial Pharmaceuticals seller in Q1 2024 was Armistice Capital, an estimated $296K sold.
Based on aggregated 13F filings for Q1 2024.